Haemonetics Corp (HAE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 03-2008 | 12-2007 | 09-2007 | 06-2007 | 03-2007 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 133,553 | 116,857 | 154,983 | 216,056 | 229,227 |
| Receivables | 120,252 | 108,811 | 100,896 | 91,917 | 91,832 |
| Inventories | 65,388 | 63,847 | 66,069 | 68,209 | 61,797 |
| Income taxes - deferred | 12,058 | 12,863 | 18,411 | 11,064 | 11,748 |
| TOTAL | $359,434 | $327,256 | $361,001 | $403,066 | $403,671 |
| Non-Current Assets | |||||
| PPE Net | 116,484 | 110,439 | 103,792 | 95,330 | 90,775 |
| Intangibles | 118,555 | 115,981 | 72,822 | 69,762 | 68,815 |
| Other Non-Current Assets | 14,477 | 11,856 | 11,075 | 9,946 | 9,474 |
| TOTAL | $249,516 | $238,276 | $187,689 | $175,038 | $169,064 |
| Total Assets | $608,950 | $565,532 | $548,690 | $578,104 | $572,735 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 19,724 | 15,790 | 17,665 | 17,740 | 17,187 |
| Accrued Expenses | 19,824 | 33,579 | 15,698 | 14,903 | 14,522 |
| Other current liabilities | N/A | 24,807 | 37,539 | 33,839 | 26,944 |
| TOTAL | $97,677 | $80,382 | $89,935 | $86,115 | $82,017 |
| Non-Current Liabilities | |||||
| Long Term Debt | 6,037 | 6,202 | 6,361 | 6,522 | 6,675 |
| Other Non-Current Liabilities | 7,795 | 5,248 | 4,668 | 8,912 | 4,395 |
| TOTAL | $17,085 | $11,450 | $11,029 | $15,434 | $11,070 |
| Total Liabilities | $114,762 | $91,832 | $100,964 | $101,549 | $93,087 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 51,439 | 51,243 | 50,823 | 52,653 | 53,087 |
| Common Shares | 256 | 256 | 254 | 262 | 265 |
| Retained earnings | 302,196 | 288,799 | 274,442 | 302,515 | 315,767 |
| Other shareholders' equity | 4,803 | 3,389 | 2,089 | 1,015 | -199 |
| TOTAL | $494,188 | $473,700 | $447,726 | $476,555 | $479,648 |
| Total Liabilities And Equity | $608,950 | $565,532 | $548,690 | $578,104 | $572,735 |